COVID-19 Vaccination Spring Boosters 2024

Posted on:

COVID-19 vaccination spring boosters 2024 for eligible patients aged 18+ – final reminder

We are holding our main clinics on Saturday 27th and Sunday 28th April 8am – 2pm and have added additional clinics on Wednesday 15th and 22nd May – these are all by appointment only and can be booked via reception or you may be sent a booking link.

We will be holding a cake stall on Saturday 27th April to raise money for SMILE (St Mary’s Immediate & Long-term Equipment fund) and Macmillan Cancer care. Please support this if you are able, either in person on the day or by scanning the QR code below.

For patients who are truly housebound we are arranging for our staff to come and do home visits from the 1st – 9th May and these will all be pre-booked. We will also be visiting Vera James House and The Orchards care homes to vaccinate residents on the 2nd and 3rd May.

If you are eligible for a vaccine and unable to attend any of our planned clinics, please look for alternative venues by phoning 119 or clicking Here.

The only vaccine we will be supplied with is The Moderna COVID-19 Vaccine (2023-2024 Formula) includes a monovalent (single) component that corresponds to the Omicron variant XBB.1.5 of SARS-CoV-2.  For further information on the vaccine please Click Here

The eligibility groups have changed for this booster – please see below for details of who is eligible:

  • 75+ Cohort adults aged 75 years and over – any setting – e.g. own home, residential village, motorhome etc.
  • Care Homes Programme residents in a care home for older adults – All residents in CQC Older Age Care homes regardless of age.
  • Immunosuppressed Cohort individuals aged 6 months and over who are immunosuppressed.
  • Immunosuppression due to disease or treatment, including:
  • Those undergoing chemotherapy or radiotherapy, solid organ transplant recipients, bone marrow or stem cell transplant recipients.
  • Genetic disorders affecting the immune system (e.g. deficiencies of IRAK-4 or NEMO, complement disorder, SCID).
  • Those with haematological malignancy, including leukaemia and lymphoma.
  • Those receiving immunosuppressive or immunomodulating biological therapy.
  • Those treated with or likely to be treated with high or moderate dose corticosteroids.
  • Those receiving any dose of non-biological oral immune modulating drugs e.g. methotrexate, azathioprine, 6-mercaptopurine or mycophenolate.
  • Those with auto-immune diseases who may require long term immunosuppressive treatments. Children who are about to receive planned immunosuppressive therapy should be considered for vaccination prior to commencing therapy.